Mindray settles unspecified Beckman Coulter beef for $15M

November 13, 2013 by Arezu Sarvestani

Chinese medical device maker Mindray Medical pays $15 million to settle a "commercial dispute" with Beckman Coulter.

Mindray settles Beckman Coulter beef for $15M

China's Mindray Medical (NYSE:MR) announced today that it took a $15 million "litigation charge" to settle an unspecified "commercial dispute" with Beckman Coulter Inc. (NYSE:BEC).

Mindray said little other than that the dispute was unrelated to any intellectual property or product liability matters, but the companies have a history.

Sign up to get our free newsletters delivered right to your inbox.

Mindray and Beckman in 2009 mutually agreed to terminate a joint development and OEM agreement for a chemical analyzer, SEC filings show. The termination resulted in a one-time $14 million payment to Mindray.

"The agreement resulted from changes in business strategy by Beckman Coulter, Inc. after it acquired the Olympus Diagnostic division," Mindray said at the time.

Mindray did not return requests for comment.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp